Navigation Links
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Date:3/11/2008

cations generally due to restoration of muscle function (8.0%) and dysgeusia (12.6%).

About ZEMURON

ZEMURON (rocuronium bromide) is a non-depolarizing muscle relaxant. It was introduced in the United States in 1994 and is one of the most widely used muscle relaxants in the United States, Canada and many European countries (where it is marketed under the brand name ESMERON). It was approved for use in Japan on July 31, 2007, under the brand name ESLAX. To date, it has been used in over 140 million patients worldwide, including an estimated 20 million patients in 2006.

Important Safety Information About ZEMURON

There have been rare reports of severe anaphylactic reactions to ZEMURON (rocuronium bromide) Injection, including some that have been life threatening. Clinicians should be prepared for the possibility of these reactions and take the necessary precautions, including the immediate availability of emergency treatment. ZEMURON Injection should be administered by experienced clinicians who are familiar with the drug's actions and the possible complications of its use. For Full Prescribing Information please go to http://www.zemuron.com or http://www.esmeron.com.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the do
'/>"/>

SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
9. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
10. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
11. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  Recognizing the unique position ... two of the most respected organizations in the New England ... Medical Device Industry Council (MassMEDIC), have partnered to celebrate ... st Annual Massachusetts Medtech Week. This celebration will take ... Convention Center in Boston . For ...
(Date:4/27/2015)... April 27, 2015 Array BioPharma ... for the third quarter of fiscal 2015 ... those results on Monday, May 4, 2015.  ... the call.Date:Monday, May 4, 2015Time:9:00 a.m. Eastern ... Replay and Conference Call Slides:  http://edge.media-server.com/m/p/8tsxszuw/lan/en ...
(Date:4/27/2015)... , April 27, 2015 NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... Conference in Boston, MA on Thursday, ... A webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
Breaking Medicine Technology:First Annual Massachusetts Medtech Week Celebrated this May 2First Annual Massachusetts Medtech Week Celebrated this May 3NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference 2
... 20, 2010 Optimer Pharmaceuticals, Inc. (Nasdaq: ... has joined Optimer as Senior Vice President of ... for the planned commercialization of fidaxomicin.  He brings ... in the healthcare and pharmaceutical industry managing pharmaceutical ...
... 2010 Stereotaxis, Inc. (Nasdaq: STXS ) announced ... $40 million credit facility, which includes a $30 million revolving ... million term loan that matures on December 31, 2013.  The ... the Company,s previous facility that was scheduled to mature in ...
Cached Medicine Technology:Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 2Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 3Stereotaxis Completes $40 Million Credit Facility 2Stereotaxis Completes $40 Million Credit Facility 3
(Date:4/27/2015)... Jesse L. Goodman, M.D., M.P.H., has been elected ... at the recently concluded Convention Meeting in Washington, D.C. ... and the Director of its Center on Medical Product ... a volunteer position, Dr. Goodman will preside at the ... member, ex officio, of the Board of Trustees and ...
(Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the DSM-5®" ... Publishing, a division of the American Psychiatric Association. The ... Press Club in Washington, D.C.. The launch event will ... Paul Summergrad, MD. Guest speakers will include Former Congressman ... book; Paul Gionfriddo, President and CEO of Mental Health ...
(Date:4/27/2015)... UC Davis investigators have settled a ... inherited disorder that historically affected Ashkenazi Jews from ... populations of Semitic descent, particularly families from Saudi ... the researchers uncovered the biochemical underpinnings of Canavan ... incurable and progressively fatal neurological condition. The UC ...
(Date:4/27/2015)... 2015 Fitness expert Samir Becic, four-time ... a health and fitness revolution, teaming up with several ... For several years, Houston, the fourth largest city in ... cities in America. With help from his friends, Becic ... of the fittest and healthiest cities in the nation. ...
(Date:4/27/2015)... April 27, 2015 Based in the ... is one of the few insurance marketing organizations in ... income and asset protection markets as well as employer ... has afforded Secura Consultants the opportunity to consult with ... doing business easier and quicker. , An example of ...
Breaking Medicine News(10 mins):Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Houston Celebrities Take a Stand and Rebel Against Obesity 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2
... gap between fitness and ... in America, RANCHO SANTA MARGARITA, Calif., Feb. 11 ... that bridges,the gap between fitness and medicine, leading to ... of learning objectives. It combines,wellness coaching with lifestyle changes, ...
... The Health,Care District of Palm Beach County today announced ... of Commissioners, has been named a,"Trustee of the Year ... annual recognition program. Dr. Pierce received the,award for the ... more than $75 million in annual revenue or more ...
... Tornado Relief Funding Totals $60,000; Emergency Call Center Activated ... ... The AT&T,Foundation, the corporate philanthropy organization of AT&T Inc. (NYSE: ... efforts across,Tennessee. In further support of the victims of this ...
... M.D., professor of medicine and director of the Rebecca and ... San Diego (UCSD) has identified a potent new anti-cancer drug ... Pacific. The properties of somocystinamide A (ScA) are described ... of the National Academy of Science the week of February ...
... AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology and medical image ... the fourth quarter and full year ended December 31, 2007, before the,market ... http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: ... -- Call begins promptly at ...
... lead to less controversial method of treating diseases , , ... they,ve reprogrammed human skin cells into ones with the ... that could aid in treating many diseases while sidestepping ... to become every cell type found in the human ...
Cached Medicine News:Health News:Spencer Institute Announces Wellness Coaching: Innovative Certification Training for Life Coaching 2Health News:Health Care District's Board Chair Nationally Recognized as a Modern Healthcare 'Trustee of the Year' 2Health News:Health Care District's Board Chair Nationally Recognized as a Modern Healthcare 'Trustee of the Year' 3Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 2Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 3Health News:UCSD research team identifies novel anticancer drug from the sea 2Health News:AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: